CTRI/2013/03/003444已完成2 期
Safety and efficacy of TRC150094 in treatment of cardio-metabolic risk inoverweight/obese diabetic subjects with dyslipidemia
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 225
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male and female subjects in the age range 30 year to 65 (Both inclusive)years
- •Waist circumference in men >=90 cm and women >=80 cm
- •BMI in the range 23-35 (inclusive) kg/m2
- •Fasting glucose >=126 mg/dL or HbA1C>=6.4 or stabilized on treatment with <=2 oral hypoglycemic agents other than alpha glucosidase inhibitors
- •ApoB >= 100mg/dL
- •Triglyceride >=150mg/dL
- •Blood pressure SBP >=130 mmHg and DBP >=85 mmHg with or without anti-hypertensive treatment
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Safety and efficacy of TRC150094 in reduction of risk for developing heart and metabolism related disorders in overweight/obese pre-diabetic subjects with abnormal lipid profileCTRI/2013/03/003445Torrent Pharmaceuticals Limited225
进行中（未招募）
1 期
Safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c >= 6 % or type 2 diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as an add-on to conventional treatment for heart failureheart failure associated with impaired glucose tolerance or type 2 diabetesMedDRA version: 9.1Level: LLTClassification code 10019279Term: Heart failureEUCTR2008-006237-27-NLTorrent Pharmaceuticals Ltd.300
尚未招募
2 期
Safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c >= 6.5 % or type 2 diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as an add-on to conventional treatment for heart failure1001928010012653heart failurediabetesNL-OMON33519Torrent Pharmaceuticals Ltd.15
进行中（未招募）
1 期
Safety and efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1c >= 6 % or type 2 diabetes receiving oral hypoglycaemic therapy (with or without additional insulin) as an add-on to conventional treatment for heart failureheart failure associated with impaired glucose tolerance or type 2 diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10019279Term: Heart failureEUCTR2008-006237-27-GBTorrent Pharmaceuticals Ltd.300
已完成
2 期
A Phase II clinical trial to study the effects of TRC4186, an investigational new drug in patients with stable heart failure associated with HbA1C â?¥ 6.0% or type 2 diabetes mellitus receiving oral anti-diabetic drug with or without insulin.CTRI/2009/091/000043Torrent Pharmaceutical Ltd300